Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.37, read 2026-11-05
Ethical passes the values gate
Price262.91 USD
Fair value339.42
Ethical score70.0/100
Value readUndervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-10-21Read Distribution274.80-4.3% to today ✓Markup gives way to Distribution after an 8% slide in 10 days
2026-10-11Read Markup297.92-11.8% to today Markdown gives way to Markup first Markup read since July
2026-09-06Read Markdown296.14-11.2% to today ✓Distribution gives way to Markdown after a 10% slide in 4 weeks
2026-08-06Read Distribution330.84-20.5% to today ✓Markup gives way to Distribution after a 26% slide in 5 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
MYR Group Inc. holds its Distribution at $262.91. Consolidating, no directional conviction, held for 64 days.
As held on the ledger · 2026-11-06
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 64 days
Price at the screen
$262.91
Valuation
21.45 trailing · 17.09 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.37
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
6.30%
Below 33%
Interest-bearing debt is just 6.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
45.62%
Below 49%
Money owed to the company is 45.6% of assets, under the 49% limit.
Pass
Revenue purity
0.02%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
MYR clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 6%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MYRG's ethical verdict changes
Today MYRG passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 6 Nov 2026: it trades at roughly a 23% discount to our $339.42 fair value, 32.50% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 22.5% discount to the base estimate.
Where our models see it going: fair-value estimate $339.42, with a range of $297.90 to $390.33, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Grid contractor priced past its fair value
Every time a substation upgrade or data centre link gets built, crews from this US electrical contractor are probably on the job. Yet the shares sit 7% above our fair value estimate and carry a forward multiple of 29 times earnings despite a thin 4% profit margin.
Revenue is expanding at 20% and return on equity reaches 23%, yet the unknown moat and lack of any margin of safety leave us on the sidelines. Analyst targets sit higher still, but the current price already bakes in perfection the numbers do not support.
Construction work remains exposed to project delays, cost inflation and regional spending cycles. The ethical screen clears, yet valuation alone keeps the opportunity rating at none. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MYRG trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Distribution$291.59+6.1%Entry 17
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455.
2026-10-28Distribution$274.80+0.0%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Distribution$274.80+0.0%Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Distribution$274.80+0.0%Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Distribution$274.80+0.0%Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Distribution$274.80+0.0%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Distribution$274.80+0.0%Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Distribution$274.80+0.0%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markup$285.57-4.1%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 85% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (6 analysts) rates it none, with a mean price target of $455.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
